Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Jump to bottom

[Bug]: integration test failure #379

Closed
3 tasks done
BFalquet opened this issue Apr 30, 2024 · 0 comments · Fixed by #381
Closed
3 tasks done

[Bug]: integration test failure #379

BFalquet opened this issue Apr 30, 2024 · 0 comments · Fixed by #381
Assignees
@BFalquet
Labels
bug Something isn't working

Comments

@BFalquet
Copy link
Contributor

What happened?

══ Failed tests ════════════════════════════════════════════════════════════════
  ── Failure ('test-assaySpec.R:39:3'): assaySpecServer module works as expected in the test app ──
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Failure ('test-assaySpec.R:46:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "rpkm" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('rpkm')
  ── Failure ('test-assaySpec.R:49:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"rpkm\"" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('[1] "rpkm"')
  ── Failure ('test-assaySpec.R:54:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"voom\"" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('[1] "voom"')
  ── Failure ('test-assaySpec.R:60:3'): assaySpecServer module works as expected in the test app ──
  `res` (`actual`) not identical to "[1] \"\"" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('[1] ""')
  ── Failure ('test-forest.R:40:3'): forest_tte module works as expected in the test app ──
  `res` (`actual`) not identical to "hd1" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('hd1')
  ── Failure ('test-forest.R:43:3'): forest_tte module works as expected in the test app ──
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Error ('test-forest.R:51:3'): forest_tte module works as expected in the test app ──
  Error in `app_wait_for_value(self, private, input = input, output = output, 
      export = export, ..., ignore = ignore, timeout = timeout, 
      interval = interval)`: timeout reached when waiting for input: NA-module-assay-name
  Backtrace:
      ▆
   1. └─app$wait_for_value(input = ns("assay-name")) at test-forest.R:51:3
   2.   └─shinytest2:::app_wait_for_value(...)
   3.     └─shinytest2:::app_abort(...)
   4.       └─rlang::abort(..., app = self, call = call)
  ── Failure ('test-km.R:41:3'): km module works as expected in the test app ─────
  `res` (`actual`) not identical to "hd1" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('hd1')
  ── Failure ('test-km.R:44:3'): km module works as expected in the test app ─────
  res$message (`actual`) not identical to "No assays eligible for this experiment, please make sure to add normalized assays" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('No assays eligible for this experiment, please make sure to add normalized assays')
  ── Failure ('test-km.R:51:3'): km module works as expected in the test app ─────
  `res` (`actual`) not identical to "cpm" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('cpm')
  ── Failure ('test-km.R:59:3'): km module works as expected in the test app ─────
  res$message (`actual`) not identical to "please select an endpoint" (`expected`).
  
  `actual` is NULL
  `expected` is a character vector ('please select an endpoint')
  ── Failure ('test-km.R:64:3'): km module works as expected in the test app ─────
  Snapshot of code has changed:
  old vs new
    Code
      cat(res)
  - Output
  -   $binned_adtte
  -                    USUBJID low_depth_flag tech_failure_flag Filename
  -   3   AB12345-CHN-1-id-307          FALSE             FALSE     eset
  -   9  AB12345-CHN-15-id-201          FALSE             FALSE     eset
  -   11   AB12345-CHN-4-id-73          FALSE             FALSE     eset
  -   18   AB12345-CHN-7-id-28          FALSE             FALSE     eset
  -   24 AB12345-NGA-11-id-173           TRUE             FALSE     eset
  -   30 AB12345-PAK-11-id-268          FALSE             FALSE     eset
  -   34   AB12345-RUS-1-id-52          FALSE             FALSE     eset
  -   39  AB12345-USA-1-id-261          FALSE             FALSE     eset
  -   41   AB12345-USA-1-id-45          FALSE             FALSE     eset
  -              AGEGRP AGE18                STDDRS
  -   3  12 - <18 years  < 18                 DEATH
  -   9     >= 18 years >= 18                 DEATH
  -   11  6 - <12 years  < 18                 DEATH
  -   18 12 - <18 years  < 18                      
  -   24  6 - <12 years  < 18                 DEATH
  -   30    >= 18 years >= 18 WITHDRAWAL BY SUBJECT
  -   34  6 - <12 years  < 18                 DEATH
  -   39 12 - <18 years  < 18                      
  -   41    >= 18 years >= 18                 DEATH
  -                                  STDDRSD    STDSSDT                TRTDRS
  -   3  DEATH DUE TO PROGRESSION OF DISEASE 07/24/2016   PROGRESSIVE DISEASE
  -   9  DEATH DUE TO PROGRESSION OF DISEASE 08/12/2016   PROGRESSIVE DISEASE
  -   11 DEATH DUE TO PROGRESSION OF DISEASE 04/19/2016   PROGRESSIVE DISEASE
  -   18                                                  PROGRESSIVE DISEASE
  -   24 DEATH DUE TO PROGRESSION OF DISEASE 09/11/2016   PROGRESSIVE DISEASE
  -   30               WITHDRAWAL BY SUBJECT 07/05/2016 WITHDRAWAL BY SUBJECT
  -   34 DEATH DUE TO PROGRESSION OF DISEASE 10/23/2016   PROGRESSIVE DISEASE
  -   39                                                  PROGRESSIVE DISEASE
  -   41 DEATH DUE TO PROGRESSION OF DISEASE 01/08/2016   PROGRESSIVE DISEASE
  -                     TRTDRSD BHDCIRC BHDCIRCU ADAFL BLANP BKPS BLKS BTANNER
  -   3  PROGRESSION OF DISEASE      NA              Y    NA   80   80      NA
  -   9  PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   11 PROGRESSION OF DISEASE      NA              Y    70   NA   70      NA
  -   18 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   24 PROGRESSION OF DISEASE      NA              Y    NA  100  100      NA
  -   30  WITHDRAWAL BY SUBJECT      NA              Y    70   NA   70      NA
  -   34 PROGRESSION OF DISEASE      NA              Y   100   NA  100      NA
  -   39 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -   41 PROGRESSION OF DISEASE      NA              Y    NA   90   90      NA
  -               FRPST   DURIDX    DURSAF     DURSUR LNTHRPY AENCIFL STUDYID
  -   3  POST-MENARCHAL 61.66735 1.6755647  5.1581109       5      NA AB12345
  -   9                 10.84189 0.9856263  3.0554415       4      NA AB12345
  -   11                45.66735 1.6755647  3.1540041      10      NA AB12345
  -   18 POST-MENARCHAL 19.54825 1.7412731  9.6919918       4      NA AB12345
  -   24                99.28542 3.5811088  6.3408624       7      NA AB12345
  -   30                16.09856 0.9856263  0.6899384       2      NA AB12345
  -   34  PRE-MENARCHAL       NA 1.6755647 10.9404517       3      NA AB12345
  -   39                41.62628 1.6755647 18.8583162       3      NA AB12345
  -   41                45.73306 0.6570842  2.2997947       2      NA AB12345
  -               RFSTDTC          RFENDTC         RFXSTDTC         RFXENDTC
  -   3  2016-03-10T14:05 2016-03-31T15:49 2016-03-10T14:05 2016-03-31T15:49
  -   9  2016-05-31T14:10 2016-05-31T14:10 2016-05-31T14:10 2016-05-31T14:10
  -   11 2016-01-25T14:15 2016-02-15T10:40 2016-01-25T14:15 2016-02-15T10:40
  -   18 2016-12-06T13:09 2016-12-29T15:46 2016-12-06T13:09 2016-12-29T15:46
  -   24 2016-03-21T15:40 2016-06-08T18:00 2016-03-21T15:40 2016-06-08T18:00
  -   30 2016-06-15T12:45 2016-06-15T12:45 2016-06-15T12:45 2016-06-15T12:45
  -   34 2015-12-01T12:25 2015-12-22T14:10 2015-12-01T12:25 2015-12-22T14:10
  -   39 2016-02-08T12:37 2016-02-29T14:15 2016-02-08T12:37 2016-02-29T14:15
  -   41 2015-11-05T11:00 2015-11-05T11:00 2015-11-05T11:00 2015-11-05T11:00
  -         RFICDTC   RFPENDTC     DTHDTC DTHFL SITEID  INVID AGE  AGEU SEX
  -   3  2016-02-18 2016-07-24 2016-07-24     Y 283495 223804  12 YEARS   F
  -   9  2016-05-11 2016-08-12 2016-08-12     Y 282087 468105  27 YEARS   F
  -   11 2016-01-14 2016-04-19 2016-04-19     Y 280959  20842  10 YEARS   F
  -   18 2016-11-28                             282703 301818  17 YEARS   M
  -   24 2016-03-02 2016-09-11 2016-09-11     Y 283497 241874   7 YEARS   F
  -   30 2016-06-14 2016-07-05                  283662 244110  19 YEARS   F
  -   34 2015-11-25 2016-10-23 2016-10-23     Y 283971 235545  11 YEARS   F
  -   39 2016-02-01                             281049 457179  16 YEARS   F
  -   41 2015-10-30 2016-01-08 2016-01-08     Y 283971 235545  19 YEARS   F
  -                           RACE                 ETHNIC ARMCD       ARM ACTARMCD
  -   3                      WHITE NOT HISPANIC OR LATINO  COH3  COHORT 3     COH3
  -   9                    UNKNOWN           NOT REPORTED COH9E COHORT 9E    COH9E
  -   11                   UNKNOWN           NOT REPORTED  COH3  COHORT 3     COH3
  -   18                   UNKNOWN           NOT REPORTED  COH2  COHORT 2     COH2
  -   24 BLACK OR AFRICAN AMERICAN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -   30                     ASIAN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -   34                     WHITE NOT HISPANIC OR LATINO COH7A COHORT 7A    COH7A
  -   39                     ASIAN NOT HISPANIC OR LATINO  COH1  COHORT 1     COH1
  -   41                   UNKNOWN     HISPANIC OR LATINO  COH6  COHORT 6     COH6
  -        ACTARM COUNTRY      DMDTC DMDY BAGE BAGEU   BWT BWTU BHT BHTU     BBMI
  -   3  COHORT 3     CHN 2016-02-18  -21   12 YEARS  50.0   kg 157   cm 20.28480
  -   9  COHORT 9     CHN 2016-05-25   -6   27 YEARS  61.6   kg 173   cm 20.58204
  -   11 COHORT 3     CHN 2016-01-14  -11   10 YEARS  29.4   kg 148   cm 13.42221
  -   18 COHORT 2     CHN 2016-11-28   -8   17 YEARS  38.2   kg 151   cm 16.75365
  -   24 COHORT 6     NGA 2016-03-02  -19    7 YEARS  53.9   kg 176   cm 17.40057
  -   30 COHORT 6     PAK 2016-06-14   -1   19 YEARS  51.0   kg 152   cm 22.07410
  -   34 COHORT 7     RUS 2015-11-25   -6   11 YEARS  36.2   kg 130   cm 21.42012
  -   39 COHORT 1     USA 2016-02-01   -7   16 YEARS 104.7   kg 172   cm 35.39075
  -   41 COHORT 6     USA 2015-10-30   -6   19 YEARS  57.0   kg 172   cm 19.26717
  -      ITTFL SAFFL    INFCODT     RANDDT          TRTSDTC             TRTSDTM
  -   3      Y     Y 2016-02-18 2016-03-09 2016-03-10T14:05 2016-03-10 14:05:00
  -   9      Y     Y 2016-05-11 2016-05-31 2016-05-31T14:10 2016-05-31 14:10:00
  -   11     Y     Y 2016-01-14 2016-01-22 2016-01-25T14:15 2016-01-25 14:15:00
  -   18     Y     Y 2016-11-28 2016-12-02 2016-12-06T13:09 2016-12-06 13:09:00
  -   24     Y     Y 2016-03-02 2016-03-21 2016-03-21T15:40 2016-03-21 15:40:00
  -   30     Y     Y 2016-06-14 2016-06-15 2016-06-15T12:45 2016-06-15 12:45:00
  -   34     Y     Y 2015-11-25 2015-12-01 2015-12-01T12:25 2015-12-01 12:25:00
  -   39     Y     Y 2016-02-01 2016-02-03 2016-02-08T12:37 2016-02-08 12:37:00
  -   41     Y     Y 2015-10-30 2015-11-05 2015-11-05T11:00 2015-11-05 11:00:00
  -      TRTSTMF             TRTEDTM TRTETMF TRTDUR DISCSTUD DISCDEAT DISCAE DISTRTFL
  -   3        S 2016-03-31 16:55:59       S     22        Y        Y      N        Y
  -   9        S 2016-05-31 15:10:59       S      1        Y        Y      N        Y
  -   11       S 2016-02-15 11:10:59       S     22        Y        Y      N        Y
  -   18       S 2016-12-29 16:19:59       S     24        N        N      N        Y
  -   24       S 2016-06-08 18:30:59       S     80        Y        Y      N        Y
  -   30       S 2016-06-15 13:45:59       S      1        Y        N      N        Y
  -   34       S 2015-12-22 14:40:59       S     22        Y        Y      N        Y
  -   39       S 2016-02-29 14:48:59       S     22        N        N      N        Y
  -   41       S 2015-11-05 12:00:59       S      1        Y        Y      N        Y
  -      AEWITHFL     ALIVDT
  -   3         N 2016-07-24
  -   9         N 2016-08-12
  -   11        N 2016-04-19
  -   18        N 2017-09-19
  -   24        N 2016-09-11
  -   30        N 2016-07-05
  -   34        N 2016-10-23
  -   39        N 2017-08-28
  -   41        N 2016-01-08
  -                                                             COHORT
  -   3                                       Cohort 3 (NEUROBLASTOMA)
  -   9  Cohort 9 (OTHER TUMOR TYPES WITH DOCUMENTED PD-L1 EXPRESSION)
  -   11                                      Cohort 3 (NEUROBLASTOMA)
  -   18                                   Cohort 2 (HODGKIN LYMPHOMA)
  -   24                                       Cohort 6 (OSTEOSARCOMA)
  -   30                                       Cohort 6 (OSTEOSARCOMA)
  -   34                                  Cohort 7 (RHABDOMYOSARCOMA )
  -   39                                      Cohort 1 (EWING SARCOMA)
  -   41                                       Cohort 6 (OSTEOSARCOMA)
  -                                                                                           TTYPE
  -   3                                                                               NEUROBLASTOMA
  -   9  GERM CELL TUMOR - YOLK SAC TUMOR (ENDODERMAL SINUS TUMOR) WITH DOCUMENTED PD-L1 EXPRESSION
  -   11                                                                              NEUROBLASTOMA
  -   18                                                                           HODGKIN LYMPHOMA
  -   24                                                                               OSTEOSARCOMA
  -   30                                                                               OSTEOSARCOMA
  -   34                                                                RHABDOMYOSARCOMA - ALVEOLAR
  -   39                                                                              EWING SARCOMA
  -   41                                                                               OSTEOSARCOMA
  -      STDSSDY                SUBJID Mean.ABCF2..ABO.         INVNAM         TRT01P
  -   3      137  AB12345-CHN-1-id-307         7.673103  Dr. CHN-1 Doe     B: Placebo
  -   9       74 AB12345-CHN-15-id-201         7.433943 Dr. CHN-15 Doe C: Combination
  -   11      86   AB12345-CHN-4-id-73         7.856089  Dr. CHN-4 Doe      A: Drug X
  -   18      NA   AB12345-CHN-7-id-28         7.454552  Dr. CHN-7 Doe     B: Placebo
  -   24     175 AB12345-NGA-11-id-173         7.702519 Dr. NGA-11 Doe C: Combination
  -   30      21 AB12345-PAK-11-id-268         7.324474 Dr. PAK-11 Doe      A: Drug X
  -   34     328   AB12345-RUS-1-id-52         7.410471  Dr. RUS-1 Doe      A: Drug X
  -   39      NA  AB12345-USA-1-id-261         7.662349  Dr. USA-1 Doe     B: Placebo
  -   41      65   AB12345-USA-1-id-45         7.780904  Dr. USA-1 Doe      A: Drug X
  -              TRT01A     TRT02P         TRT02A       REGION1 STRATA1 STRATA2
  -   3      B: Placebo B: Placebo C: Combination          Asia       C      S1
  -   9  C: Combination B: Placebo C: Combination          Asia       C      S2
  -   11      A: Drug X B: Placebo C: Combination          Asia       A      S1
  -   18     B: Placebo B: Placebo     B: Placebo          Asia       C      S2
  -   24 C: Combination B: Placebo      A: Drug X        Africa       C      S2
  -   30      A: Drug X B: Placebo      A: Drug X          Asia       C      S2
  -   34      A: Drug X B: Placebo C: Combination       Eurasia       C      S2
  -   39     B: Placebo B: Placebo     B: Placebo North America       C      S1
  -   41      A: Drug X  A: Drug X      A: Drug X North America       C      S1
  -          BMRKR1 BMRKR2 BMEASIFL BEP01FL           TRT01SDTM           TRT01EDTM
  -   3   4.5749910    LOW        Y       N 2019-03-11 08:01:26 2021-02-18 02:48:40
  -   9   6.9067988 MEDIUM        Y       N 2019-03-05 15:24:07 2021-02-18 22:06:48
  -   11  2.8631240 MEDIUM        Y       Y 2019-03-17 14:18:17 2021-02-14 13:35:43
  -   18 11.1444470 MEDIUM        N       N 2019-03-11 09:11:52 2021-03-10 21:11:52
  -   24  4.9972257    LOW        Y       Y 2019-03-10 09:35:30 2021-03-09 21:35:30
  -   30  2.8201408 MEDIUM        N       N 2019-03-21 23:53:53 2021-03-21 11:53:53
  -   34  7.2063482   HIGH        N       N 2019-03-18 09:38:55 2021-02-13 06:30:28
  -   39  2.8551642   HIGH        Y       N 2019-03-06 17:21:21 2021-03-06 05:21:21
  -   41  0.4635604    LOW        N       N 2019-03-06 06:32:29 2021-03-05 18:32:29
  -                TRT02SDTM           TRT02EDTM            AP01SDTM
  -   3  2021-02-18 02:48:40 2022-02-18 08:48:40 2019-03-11 08:01:26
  -   9  2021-02-18 22:06:48 2022-02-19 04:06:48 2019-03-05 15:24:07
  -   11 2021-02-14 13:35:43 2022-02-14 19:35:43 2019-03-17 14:18:17
  -   18 2021-03-10 21:11:52 2022-03-11 03:11:52 2019-03-11 09:11:52
  -   24 2021-03-09 21:35:30 2022-03-10 03:35:30 2019-03-10 09:35:30
  -   30 2021-03-21 11:53:53 2022-03-21 17:53:53 2019-03-21 23:53:53
  -   34 2021-02-13 06:30:28 2022-02-13 12:30:28 2019-03-18 09:38:55
  -   39 2021-03-06 05:21:21 2022-03-06 11:21:21 2019-03-06 17:21:21
  -   41 2021-03-05 18:32:29 2022-03-06 00:32:29 2019-03-06 06:32:29
  -                 AP01EDTM            AP02SDTM            AP02EDTM       EOSSTT
  -   3  2021-02-18 02:48:40 2021-02-18 02:48:40 2022-02-18 08:48:40 DISCONTINUED
  -   9  2021-02-18 22:06:48 2021-02-18 22:06:48 2022-02-19 04:06:48 DISCONTINUED
  -   11 2021-02-14 13:35:43 2021-02-14 13:35:43 2022-02-14 19:35:43 DISCONTINUED
  -   18 2021-03-10 21:11:52 2021-03-10 21:11:52 2022-03-11 03:11:52    COMPLETED
  -   24 2021-03-09 21:35:30 2021-03-09 21:35:30 2022-03-10 03:35:30    COMPLETED
  -   30 2021-03-21 11:53:53 2021-03-21 11:53:53 2022-03-21 17:53:53    COMPLETED
  -   34 2021-02-13 06:30:28 2021-02-13 06:30:28 2022-02-13 12:30:28 DISCONTINUED
  -   39 2021-03-06 05:21:21 2021-03-06 05:21:21 2022-03-06 11:21:21    COMPLETED
  -   41 2021-03-05 18:32:29 2021-03-05 18:32:29 2022-03-06 00:32:29    COMPLETED
  -            EOTSTT      EOSDT EOSDY          DCSREAS      DTHDT
  -   3  DISCONTINUED 2022-02-18  1076            DEATH 2022-04-06
  -   9  DISCONTINUED 2022-02-19  1082            DEATH 2022-02-22
  -   11 DISCONTINUED 2022-02-14  1066 LACK OF EFFICACY       <NA>
  -   18    COMPLETED 2022-03-11  1096             <NA>       <NA>
  -   24    COMPLETED 2022-03-10  1096             <NA>       <NA>
  -   30    COMPLETED 2022-03-21  1096             <NA>       <NA>
  -   34 DISCONTINUED 2022-02-13  1064            DEATH 2022-02-20
  -   39    COMPLETED 2022-03-06  1096             <NA>       <NA>
  -   41    COMPLETED 2022-03-06  1096             <NA>       <NA>
  -                  DTHCAUS              DTHCAT LDDTHELD LDDTHGR1   LSTALVDT DTHADY
  -   3    LOST TO FOLLOW UP               OTHER       47      >30 2022-04-06   1121
  -   9        ADVERSE EVENT       ADVERSE EVENT        3     <=30 2022-02-22   1084
  -   11                <NA>                <NA>       NA     <NA> 2022-03-07     NA
  -   18                <NA>                <NA>       NA     <NA> 2022-03-31     NA
  -   24                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -   30                <NA>                <NA>       NA     <NA> 2022-04-02     NA
  -   34 DISEASE PROGRESSION PROGRESSIVE DISEASE        7     <=30 2022-02-20   1069
  -   39                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -   41                <NA>                <NA>       NA     <NA> 2022-03-30     NA
  -      ADTHAUT ASEQ TTESEQ                     PARAM PARAMCD      AVAL AVALU
  -   3     <NA>    4      4 Progression Free Survival     PFS 239.08590  DAYS
  -   9      Yes    2      2 Progression Free Survival     PFS 248.53707  DAYS
  -   11    <NA>    3      3 Progression Free Survival     PFS 420.38459  DAYS
  -   18    <NA>    3      3 Progression Free Survival     PFS  30.04978  DAYS
  -   24    <NA>    2      2 Progression Free Survival     PFS 382.86110  DAYS
  -   30    <NA>    1      1 Progression Free Survival     PFS 326.40156  DAYS
  -   34     Yes    1      1 Progression Free Survival     PFS  45.07870  DAYS
  -   39    <NA>    2      2 Progression Free Survival     PFS 899.41424  DAYS
  -   41    <NA>    3      3 Progression Free Survival     PFS 131.76520  DAYS
  -                     ADTM  ADY CNSR                    EVNTDESC
  -   3  2022-02-16 08:01:26 1073    1       Last Tumor Assessment
  -   9  2020-04-05 15:24:07  397    0         Disease Progression
  -   11 2020-09-20 14:18:17  553    0                       Death
  -   18 2020-10-02 09:11:52  571    1 Last Date Known To Be Alive
  -   24 2021-09-04 09:35:30  909    0         Disease Progression
  -   30 2019-12-14 23:53:53  268    1       Last Tumor Assessment
  -   34 2019-11-14 09:38:55  241    0         Disease Progression
  -   39 2020-07-15 17:21:21  497    0                       Death
  -   41 2020-06-28 06:32:29  480    0                       Death
  -                        CNSDTDSC lgTMATRSK is_event gene_factor
  -   3            Clinical Cut Off        NA    FALSE  (50%,100%]
  -   9                                    NA     TRUE    [0%,50%]
  -   11                                   NA     TRUE  (50%,100%]
  -   18           Clinical Cut Off        NA    FALSE    [0%,50%]
  -   24                                   NA     TRUE  (50%,100%]
  -   30 End of AE Reporting Period        NA    FALSE    [0%,50%]
  -   34                                   NA     TRUE    [0%,50%]
  -   39                                   NA     TRUE    [0%,50%]
  -   41                                   NA     TRUE  (50%,100%]
  -   
  -   $variables
  -   $variables$tte
  -   [1] "AVAL"
  -   
  -   $variables$is_event
  -   [1] "is_event"
  -   
  -   $variables$arm
  -   [1] "gene_factor"
  -   
  -   $variables$strat
  -   NULL
  
  * Run `testthat::snapshot_accept('km')` to accept the change.
  * Run `testthat::snapshot_review('km')` to interactively review the change.
  ── Error ('test-pca.R:76:3'): pca module works as expected in the test app ─────
  Error in `app_find_node_id(self, private, input = input, output = output, 
      selector = selector)`: Cannot find HTML element with selector #teal-main_ui-filter_panel-active-MAE-hd1-MAE_symbol_hd1_subset-remove.shiny-bound-input
  Backtrace:
      ▆
   1. └─app$click(ns2("active-MAE-hd1-MAE_symbol_hd1_subset-remove")) at test-pca.R:76:3
   2.   └─shinytest2:::app_click(...)
   3.     └─shinytest2:::app_find_node_id(self, private, input = input, output = output, selector = selector)
   4.       └─shinytest2:::app_abort(...)
   5.         └─rlang::abort(..., app = self, call = call)
  
  [ FAIL 14 | WARN 0 | SKIP 0 | PASS 169 ]
  Error: Test failures
  Execution halted
* checking PDF version of manual ... OK
* DONE

sessionInfo()

No response

Relevant log output

No response

Code of Conduct

  • I agree to follow this project's Code of Conduct.

Contribution Guidelines

  • I agree to follow this project's Contribution Guidelines.

Security Policy

  • I agree to follow this project's Security Policy.
@BFalquet BFalquet added the bug Something isn't working label Apr 30, 2024
@BFalquet BFalquet self-assigned this Apr 30, 2024
@BFalquet BFalquet mentioned this issue May 7, 2024
Merged
BFalquet added a commit that referenced this issue May 13, 2024
@BFalquet
379 [Bug]: integration test failure (#381)
c52c525 
close #379 

small change in teal led to error during filtering.

thank you for the review
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Assignees

@BFalquet BFalquet

Labels
bug Something isn't working
Projects
None yet
Milestone
No milestone
Development

Successfully merging a pull request may close this issue.

379 [Bug]: integration test failure insightsengineering/teal.modules.hermes
1 participant
@BFalquet